Clinical Trials Browser

INDUSTRY × Cholestasis × Gemcitabine × Clear all

NCT02267707 2019-11-01

Pharmacokinetic and Safety Study of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia

Phase 1 Terminated

Gastrointestinal

Cholestasis, Pancreatic Neoplasms